Session Details

U003 Combining Systemic Therapies: Should You Do It?

Fri, Mar 19, 7:30 AM - 8:30 AM
1 CME Available Focus Session

DESCRIPTION

With the expansion of our treatment armamentaria in dermatology we have many tools in our toolbox to manage treatment failure and patients with multiple dermatologic conditions. Practicing dermatologists are now getting introduced to all these new therapies including JAK inhibitors and emerging biologics. The use of these new agents in combination with each other or with more traditional immunomodulators are not well established. This session is targeted to familiarize practicing dermatologists on how to combine these medications in our daily practice and how to assess their safety profile in this setting.

LEARNING OBJECTIVES

1.

Select the appropriate biologic and immunomodulator combinations in the real world.

2.

Manage treatment failure with combination therapy.

3.

Assess the safety profile of combining multiple agents.

SCHEDULE

7:30 AM

Introduction

Carole Bitar, MD, FAAD

7:35 AM

Combination Systemic Therapies in Connective Tissue Diseases

Carole Bitar, MD, FAAD

7:47 AM

Combination Systemic Therapies in Psoriasis

Erin E. Boh, MD, PhD, FAAD

7:59 AM

Combination systemic therapies in Hidradenitis Suppurativa

Andrea Tesvich Murina, MD, FAAD

8:11 AM

Combination Systemic therapies in Bullous Diseases

8:23 AM

Q&A session

DIRECTOR

Carole Bitar, MD, FAAD

Carole Bitar, MD, FAAD

SPEAKERS

Erin E. Boh, MD, PhD, FAAD

Erin E. Boh, MD, PhD, FAAD

Katherine Brag, MD, FAAD

Katherine Brag, MD, FAAD

Andrea Tesvich Murina, MD, FAAD

Andrea Tesvich Murina, MD, FAAD

Tulane University School of Medicine

DISCLOSURES

Carole Bitar, MD, FAAD

Arcutis Biotherapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding);

Erin E. Boh, MD, PhD, FAAD

AbbVie – Investigator(Grants/Research Funding); Alumis – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Bristol Myers Squibb – Investigator(Grants/Research Funding); CorEvitas – Investigator(Grants/Research Funding); Janssen-Ortho Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi – Investigator(Grants/Research Funding);

Katherine Brag, MD, FAAD

No financial relationships exist with ineligible companies.

Andrea Tesvich Murina, MD, FAAD

AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Speaker(Honoraria); Botanix Pharmaceuticals – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria); Novartis – Speaker/Faculty Education(Honoraria); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); UCB Pharma – Speaker(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);